SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richard Monge who wrote (3264)12/9/1997 9:17:00 PM
From: Oliver & Co  Read Replies (1) of 6136
 
I would think so.
Look at this.

======================================================================
Lawsuit Fears, Cash Crunch Hit AIDS Vaccine Hunt"
Reuters (12/08/97); Bunce, Matthew
ÿÿÿÿ UNAIDS director Peter Piot says the search for an AIDS
vaccine is being hampered by a fear of litigation and a
perception in the pharmaceutical industry that such a product
might not be profitable.ÿ If an AIDS vaccine is developed, Piot
noted, there will be cases where it does not work and paying
compensation to people for whom a vaccine fails could ruin a drug
maker.ÿ Piot added, however, that an AIDS vaccine is necessary
and should remain a long-term goal.ÿ He also called for an
international AIDS therapy solidarity fund to help Africa deal
with a large increase in the number of people infected with HIV.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext